Literature DB >> 21067978

Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.

Eiji Kawasaki1, Kan Nakamura, Genpei Kuriya, Tsuyoshi Satoh, Masakazu Kobayashi, Hironaga Kuwahara, Norio Abiru, Hironori Yamasaki, Nobuo Matsuura, Junnosuke Miura, Yasuko Uchigata, Katsumi Eguchi.   

Abstract

The aim of this study was to evaluate the humoral autoreactivity to zinc transporter 8 (ZnT8) depending on the clinical phenotype of type 1 diabetes (T1D). ZnT8 autoantibodies (ZnT8A) were determined by radioimmunoassay using carboxy-terminal ZnT8 constructs in 57 childhood-onset, 97 adult-onset, and 85 fulminant T1D. The ZnT8A frequency was higher in childhood-onset patients and decreased with increasing age of onset from 70% to 24% (P(trend)<0.005). None of the patients with fulminant T1D was positive for ZnT8A. There were at least two distinct ZnT8A epitope patterns associated with the aa325-restriction, childhood-onset patients have aa325-nonrestricted response more frequently compared to the adult-onset group (P<0.05). The level of ZnT8A was inversely associated with the copy number of HLA-DR4 allele (P<0.05). These results suggest differences in the humoral autoreactivity to ZnT8 depending on the clinical phenotype, which should provide strategy for autoantibody measurement in subjects to allow early diagnosis of autoimmune T1D.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21067978     DOI: 10.1016/j.clim.2010.10.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  16 in total

1.  Current clinical state of type 1 diabetes in Saitama prefecture.

Authors:  Yoichi Oikawa; Koshi Hashimoto; Kazuo Hara; Jiro Morimoto; Kazuyuki Namai; Akihiko Tanaka; Satoshi Tanaka; Akira Shimada
Journal:  Diabetol Int       Date:  2021-11-01

2.  A child with mitochondrial DNA deletion presenting diabetes mellitus as an initial symptom.

Authors:  Koko Nemoto; Kentaro Sano; Satoko Sato; Yasuhiro Maeda; Kei Murayama; Jun-Ichi Takanashi
Journal:  Radiol Case Rep       Date:  2022-06-17

3.  Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus.

Authors:  Eiji Kawasaki; Taro Maruyama; Akihisa Imagawa; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Yumiko Kawabata; Tetsuro Kobayashi; Akira Shimada; Ikki Shimizu; Kazuma Takahashi; Masao Nagata; Hideichi Makino; Toshiaki Hanafusa
Journal:  J Diabetes Investig       Date:  2013-08-13       Impact factor: 4.232

Review 4.  Type 1 diabetes and autoimmunity.

Authors:  Eiji Kawasaki
Journal:  Clin Pediatr Endocrinol       Date:  2014-11-06

5.  Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.

Authors:  Junichi Yasui; Eiji Kawasaki; Shoichiro Tanaka; Takuya Awata; Hiroshi Ikegami; Akihisa Imagawa; Yasuko Uchigata; Haruhiko Osawa; Hiroshi Kajio; Yumiko Kawabata; Akira Shimada; Kazuma Takahashi; Kazuki Yasuda; Hisafumi Yasuda; Toshiaki Hanafusa; Tetsuro Kobayashi
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

6.  Zinc transporters, mechanisms of action and therapeutic utility: implications for type 2 diabetes mellitus.

Authors:  Stephen A Myers; Alex Nield; Mark Myers
Journal:  J Nutr Metab       Date:  2012-12-12

7.  Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.

Authors:  Janet M Wenzlau; Lisa M Frisch; John C Hutton; Pamela R Fain; Howard W Davidson
Journal:  Diabetes Care       Date:  2015-10       Impact factor: 19.112

8.  The zinc transporter, Slc39a7 (Zip7) is implicated in glycaemic control in skeletal muscle cells.

Authors:  Stephen A Myers; Alex Nield; Guat-Siew Chew; Mark A Myers
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

9.  Zinc transporter-8 autoantibodies can replace IA-2 autoantibodies as a serological marker for juvenile onset type 1 diabetes in India.

Authors:  C Shivaprasad; Rajneesh Mittal; Mala Dharmalingam; Prasanna K Kumar
Journal:  Indian J Endocrinol Metab       Date:  2014-05

Review 10.  Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitus.

Authors:  Bo Yi; Gan Huang; Zhiguang Zhou
Journal:  J Diabetes Investig       Date:  2016-01-09       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.